Sarepta Therapeutics | SCHEDULE 13D:其他
Sarepta Therapeutics | SCHEDULE 13G/A:其他
Sarepta Therapeutics | 8-K:重大事件
Sarepta Therapeutics | 4:持股變動聲明-高管 Estepan Ian Michael
Sarepta Therapeutics | 4:持股變動聲明-高管 Rodino-Klapac Louise
Sarepta Therapeutics | 4:持股變動聲明-高管 Murray Dallan
Sarepta Therapeutics | 4:持股變動聲明-高管 Arif Bilal
Sarepta Therapeutics | 4:持股變動聲明-高管 Estepan Ian Michael
Sarepta Therapeutics | 8-K:重大事件
Sarepta Therapeutics | 4:持股變動聲明-高管 Estepan Ian Michael
Sarepta Therapeutics | 4:持股變動聲明-董事 Wigzell Hans Lennart Rudolf
Sarepta Therapeutics | 144:擬議出售證券
Sarepta Therapeutics | 4:持股變動聲明-董事 Boor Kathryn Jean
Sarepta Therapeutics | 144:擬議出售證券
Sarepta Therapeutics | 4:持股變動聲明-高管 Rothfuss Cristin
Sarepta Therapeutics | 3:首次持股聲明-高管 Rothfuss Cristin
Sarepta Therapeutics | 8-K:重大事件
Sarepta Therapeutics | 4:持股變動聲明-高管 Rodino-Klapac Louise
Sarepta Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Janus Henderson Group plc(4.6%)
Sarepta Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Capital International Investors(6.7%)